Studies have shown that miR-1827 and miRNA-766, two microRNAs targeting MDM2 and MDM4, respectively, are often downregulated in CRC samples; hence, their reduced expression in CRC may lead to impaired p53 stability (Chen et al., 2019). This evidence concerns the gene MDM4 and colorectal carcinoma.